|
Market Closed -
Australian S.E.
13:10:16 26/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.3250 AUD | -2.99% |
|
+12.07% | -50.00% |
| Market Cap | 99.38M 69.89M 62.42M 57.66M 52.25M 97.76M 6.63B 694M 275M 3.48B 262M 257M 10.96B | P/E 2027 * |
-2.09x | P/E 2028 * | 3.02x |
|---|---|---|---|---|---|
| Enterprise Value | 154M 108M 96.73M 89.36M 80.98M 151M 10.28B 1.08B 426M 5.39B 406M 398M 16.98B | EV / Sales 2027 * |
18.8x | EV / Sales 2028 * | 0.94x |
| Free-Float |
62.73% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| RCE | Delayed | |
Deutsche Boerse AG
| R9Q | Delayed | |
|
Börse Stuttgart
| R9Q | Delayed | |
|
Boerse Muenchen
| R9Q | Real-time | |
|
Tradegate
| R9Q | Real-time |
| 1 day | -2.99% | ||
| 1 week | +12.07% | ||
| Current month | +3.17% | ||
| 1 month | -1.52% | ||
| 3 months | -9.72% | ||
| 6 months | -38.68% | ||
| Current year | -50.00% |
| 1 week | 0.29 |  | 0.36 |
| 1 month | 0.26 | | 0.36 |
| Current year | 0.26 | | 0.73 |
| 1 year | 0.26 | | 0.73 |
| 3 years | 0.26 | | 0.73 |
| 5 years | 0.26 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/7/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 31/7/26 | Buy | Director | 75,000 | 0.0250% | ||
| 31/7/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.99% | +12.07% | -22.62% | -27.78% | 72.04M | |
| +0.52% | +2.94% | +54.49% | +124.74% | 1,135B | |
| +0.75% | +4.80% | +39.76% | +78.50% | 635B | |
| +0.34% | +1.40% | +25.70% | +97.41% | 505B | |
| +1.23% | +4.26% | +48.20% | +67.04% | 378B | |
| -2.49% | -0.98% | +61.62% | +34.75% | 358B | |
| -0.52% | +2.64% | +23.58% | +49.82% | 295B | |
| -0.05% | +3.39% | +2.18% | +23.36% | 266B | |
| +0.16% | +3.74% | +51.41% | +63.45% | 237B | |
| +1.61% | +3.59% | +31.63% | +102.00% | 193B | |
| Average | -0.17% | +2.99% | +31.60% | +61.33% | 400.37B | |
| Weighted average by Cap. | +0.21% | +1.63% | +41.53% | +83.46% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 8.2M 5.77M 5.15M 4.76M 4.31M 8.07M 547M 57.25M 22.67M 287M 21.64M 21.18M 904M | 54.3M 38.19M 34.1M 31.51M 28.55M 53.42M 3.63B 379M 150M 1.9B 143M 140M 5.99B |
| Net income | -47.2M -33.2M -29.64M -27.38M -24.82M -46.43M -3.15B -330M -130M -1.65B -125M -122M -5.21B | 33.4M 23.49M 20.98M 19.38M 17.56M 32.86M 2.23B 233M 92.33M 1.17B 88.16M 86.29M 3.68B |
| Net Debt | 54.63M 38.42M 34.31M 31.7M 28.72M 53.74M 3.65B 381M 151M 1.91B 144M 141M 6.02B | -48.1M -33.83M -30.21M -27.91M -25.29M -47.32M -3.21B -336M -133M -1.68B -127M -124M -5.3B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | A$0.3250 | -2.99% | 40,554 |
| 23/10/26 | A$0.3350 | -2.90% | 126,535 |
| 22/10/26 | A$0.3450 | -2.82% | 69,173 |
| 21/10/26 | A$0.3550 | +1.43% | 203,787 |
| 20/10/26 | A$0.3500 | +20.69% | 744,674 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
